InvestorsHub Logo
Followers 64
Posts 5750
Boards Moderated 0
Alias Born 07/09/2003

Re: None

Thursday, 05/10/2018 4:24:04 PM

Thursday, May 10, 2018 4:24:04 PM

Post# of 859
Mike Rice, BioLife President & CEO, commented, "We are off to a very strong start in 2018, with record revenue in Q1, 36 new direct customers gained, and operating profitability for the first time in the Company's history. BioLife is well positioned as a sole-source supplier of proprietary biopreservation media reagents to the biopharmaceutical industry, which are critical enabling components to therapies that are transforming the way leading disorders and causes of death are treated. We expect continued strong results throughout 2018, given increasing regenerative medicine investments and M&A activity and clinical development progress by our cell therapy customers that continues to drive strong demand for our products."

https://finance.yahoo.com/news/biolife-solutions-announces-first-quarter-200500025.html

techisbest

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLFS News